← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2016Last known activity
Aug 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (38 distinct, 18 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (16 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Recent trials (22)
- NCT07089862CollaboratorN/AAug 31, 2025
- NCT07078500CollaboratorPhase 2May 5, 2025
- NCT07022223CollaboratorPhase 2Mar 11, 2025
- NCT06801730OfficialPhase 2Jan 8, 2025
- NCT06801730Sponsor investigatorPhase 2Jan 8, 2025
- NCT06801730Lead sponsorPhase 2Jan 8, 2025
- NCT06520176CollaboratorPhase 3Aug 31, 2024
- NCT06520163CollaboratorPhase 3Aug 31, 2024
- NCT06462313CollaboratorN/AJul 22, 2024
- NCT06925334CollaboratorPhase 4May 20, 2024
- NCT06364046Lead sponsorN/AApr 1, 2024
- NCT06364046OfficialN/AApr 1, 2024
- NCT05791136Lead sponsorPhase 2Apr 30, 2023
- NCT05519202Lead sponsorPhase 2Aug 31, 2022
- NCT05233358Lead sponsorN/AFeb 1, 2022
Details
- Last known activity
- Aug 31, 2025